OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Oncology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Issue Information	155
	140
Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection	117
Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer	94
Ovarian cancer relies on the PDGFRβ –fibronectin axis for tumorsphere formation and metastatic spread	89
Microglia limit brain tumor development by restricting tumor cell proliferation and inducing T‐cell immunity	83
Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with	81
PoDCall: a robust tool for automated droplet classification in DNA‐methylation droplet digital PCR	79
	75
Corrigendum to: Small proline‐rich repeat protein 3 enhances the sensitivity of esophageal cancer cells in response to DNA damage‐induced apoptosis	69
Correction to “Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition”	59
NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy	58
Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo	49
Gene signature predicting recurrence in oral squamous cell carcinoma is characterized by increased oxidative phosphorylation	42
The multispecies microbial cluster of Fusobacterium , Parvimonas , Bacteroides	41
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling	38
An arms‐race against resistance: leukemic stem cells and lineage plasticity	38
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐ CD 73/anti‐	37
Nanosecond pulsed electric field ablation‐induced modulation of sphingolipid metabolism is associated with Ly6c2 ⁺ mononuc	35
Unraveling LINE ‐1 retrotransposition in head and neck squamous cell carcinoma	33
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer	32
Precision Cancer Medicine 2.0—Oncology in the postgenomic era	32
Correction to “SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression”	32
Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for	32
Exosomes secreted by ST3GAL5^high cancer cells promote peritoneal dissemination by establishing a premetastatic microenvironment	31

Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma	31
Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type‐B receptor 4	30
Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system	30
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities	29
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer	29